Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Axonics Modulation Technologies Inc
AXNXCurrent price
68.19 USD
+0.19 USD (+0.28%)
Last closed
68.01 USD
Company
www.axonics.com
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
3 454 972 928 USD
Yield for 12 month
+28.66 %
1Y
3Y
5Y
10Y
15Y
AXNX
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. Address: 26 Technology Drive, Irvine, CA, United States, 92618
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
71.73 USDP/E ratio
–Dividend Yield
–Current Year
+366 379 000 USD
Last Year
+273 702 000 USD
Current Quarter
+91 409 000 USD
Last Quarter
+109 735 000 USD
Current Year
+265 490 000 USD
Last Year
+197 665 000 USD
Current Quarter
+69 253 000 USD
Last Quarter
+80 499 000 USD
Key Figures AXNX
1 year
3 years
5 years
10 years
EBITDA
5 392 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-0.68 %
PEG Ratio
–
Return On Equity TTM
-2.65 %
Wall Street Target Price
71.73 USD
Revenue TTM
387 137 984 USD
Book Value
12.29 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
29.4 %
Dividend Yield
–
Gross Profit TTM
197 665 000 USD
Earnings per share
-0.31 USD
Diluted Eps TTM
-0.31 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
844.8 %
Profit Margin
-4.12 %
Dividend Analytics AXNX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AXNX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation AXNX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
156.25
Enterprise Value Revenue
8.5444
Price Sales TTM
9.4106
Enterprise Value EBITDA
402.6352
Price Book MRQ
5.4078
Financials AXNX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AXNX
For 52 weeks
48.3 USD
69.68 USD
50 Day MA
67.42 USD
Shares Short Prior Month
3 376 899
200 Day MA
63.87 USD
Short Ratio
9.18
Shares Short
3 400 365
Short Percent
7.52 %
BeatStart